A Prescription Trend Analysis of Methylphenidate: Relation to Study Reports on EfficacySluiter, M. N., de Vries, Y. A., Koning, L. G., Hak, E., Bos, J. H. J., Schuiling-Veninga, C. C. M., Batstra, L., Doornenbal, J. M. & de Jonge, P., Mar-2020, In : Administration and Policy in Mental Health and Mental Health Services Research . 47, 2, p. 291–299 9 p.
Research output: Contribution to journal › Article › Academic › peer-review
Use of methylphenidate in children has increased substantially, despite conflicting evidence regarding efficacy. In this study, prescription data were analyzed in relation to the publication of new evidence regarding efficacy. Incidence rates and prescribed doses of methylphenidate increased, with a decline during the last few years. Duration of use is still increasing. In half of the cases, starting dosages are higher than recommended in guidelines. There was little evidence that publication of new evidence directly influenced the use of methylphenidate. Recent and critical study findings should receive more attention to contribute to the development and use of treatment guidelines for ADHD and evidence-based methylphenidate use.
|Number of pages||9|
|Journal||Administration and Policy in Mental Health and Mental Health Services Research|
|Early online date||16-Oct-2019|
|Publication status||Published - Mar-2020|
- FOLLOW-UP, STIMULANT MEDICATION, CHILDREN, ADOLESCENTS, OUTCOMES, ADHD